Trial shows positive results for lung cancer patients taking chemotherapy plus durvalumab and tremelimumab
Patients with metastatic non-small cell lung cancer (mNSCLC) who received a combined regimen of durvalumab, tremelimumab, and chemotherapy experienced a statistically significant improvement in progression-free survival and ...
Sep 9, 2021
0
0